Genky DrugStores Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Retailing
  • ISIN: JP3282750003
JPY
4,955.00
55 (1.12%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'24
Dec'23
Sep'23
Jun'23
Mar'23
Dec'22
Sep'22
Net Sales
44,620.00
45,096.00
46,871.00
44,854.00
40,331.00
41,261.00
42,613.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
44,620.00
45,096.00
46,871.00
44,854.00
40,331.00
41,261.00
42,613.00
Raw Material Cost
35,764.00
35,661.00
37,524.00
35,643.00
32,118.00
32,713.00
34,031.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
26.00
28.00
15.00
29.00
9.00
25.00
7.00
Selling and Distribution Expenses
6,748.00
7,064.00
7,331.00
7,260.00
6,820.00
6,767.00
6,997.00
Other Expenses
-2.60
-2.80
-1.50
-2.90
-0.90
-2.50
-0.70
Total Expenditure (Excl Depreciation)
42,512.00
42,725.00
44,855.00
42,903.00
38,938.00
39,480.00
41,028.00
Operating Profit (PBDIT) excl Other Income
2108
2371
2016
1951
1393
1781
1585
Other Income
101.00
63.00
87.00
161.00
103.00
110.00
110.00
Operating Profit (PBDIT)
3,618.00
3,797.00
3,401.00
3,425.00
2,727.00
3,105.00
2,892.00
Interest
26.00
28.00
15.00
29.00
9.00
25.00
7.00
Exceptional Items
-164.00
-52.00
0.00
-226.00
0.00
-108.00
-87.00
Gross Profit (PBDT)
8,856.00
9,435.00
9,347.00
9,211.00
8,213.00
8,548.00
8,582.00
Depreciation
1,409.00
1,363.00
1,298.00
1,313.00
1,231.00
1,214.00
1,197.00
Profit Before Tax
2,019.00
2,353.00
2,088.00
1,859.00
1,488.00
1,755.00
1,602.00
Tax
651.00
709.00
644.00
407.00
446.00
586.00
500.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
1,369.00
1,643.00
1,444.00
1,451.00
1,042.00
1,169.00
1,102.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
1,369.00
1,643.00
1,444.00
1,451.00
1,042.00
1,169.00
1,102.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
1,369.00
1,643.00
1,444.00
1,451.00
1,042.00
1,169.00
1,102.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
44,799.00
43,592.00
41,953.00
40,681.00
39,205.00
38,334.00
37,152.00
Earnings per share (EPS)
89.98
108.06
94.99
95.48
68.57
76.94
72.53
Diluted Earnings per share
89.98
108.06
94.99
95.48
68.57
76.94
72.53
Operating Profit Margin (Excl OI)
4.72%
5.26%
4.3%
4.35%
3.45%
4.32%
3.72%
Gross Profit Margin
7.68%
8.24%
7.22%
7.07%
6.74%
7.2%
6.57%
PAT Margin
3.07%
3.64%
3.08%
3.23%
2.58%
2.83%
2.59%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Mar 2024 is 10.63% vs 7.48% in Mar 2023

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Mar 2024 is 31.38% vs 11.66% in Mar 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Mar 2024 is 34.03% vs 7.82% in Mar 2023

stock-summary

Interest

YoY Growth in quarter ended Mar 2024 is 188.89% vs 13.92% in Mar 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Mar 2024 has improved from Mar 2023

Compare Quarterly Results Of Genky DrugStores Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
44,620.00
1,19,970.00
-75,350.00
-62.81%
Other Operating Income
0.00
0.00
0.00
Total Operating income
44,620.00
1,19,970.00
-75,350.00
-62.81%
Raw Material Cost
35,764.00
1,00,421.00
-64,657.00
-64.39%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
26.00
87.00
-61.00
-70.11%
Selling and Distribution Expenses
6,748.00
15,233.00
-8,485.00
-55.70%
Other Expenses
-2.60
-8.70
6.10
70.11%
Total Expenditure (Excl Depreciation)
42,512.00
1,15,654.00
-73,142.00
-63.24%
Operating Profit (PBDIT) excl Other Income
2,108.00
4,316.00
-2,208.00
-51.16%
Other Income
101.00
157.00
-56.00
-35.67%
Operating Profit (PBDIT)
3,618.00
8,498.00
-4,880.00
-57.43%
Interest
26.00
87.00
-61.00
-70.11%
Exceptional Items
-164.00
-1,786.00
1,622.00
90.82%
Gross Profit (PBDT)
8,856.00
19,549.00
-10,693.00
-54.70%
Depreciation
1,409.00
4,025.00
-2,616.00
-64.99%
Profit Before Tax
2,019.00
2,601.00
-582.00
-22.38%
Tax
651.00
672.00
-21.00
-3.12%
Provisions and contingencies
0
0
0.00
Profit After Tax
1,369.00
1,905.00
-536.00
-28.14%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
1,369.00
1,905.00
-536.00
-28.14%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
24.00
-24.00
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
1,369.00
1,929.00
-560.00
-29.03%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
44,799.00
1,42,521.00
-97,722.00
-68.57%
Earnings per share (EPS)
89.98
54.29
35.69
65.74%
Diluted Earnings per share
89.98
54.29
35.69
65.74%
Operating Profit Margin (Excl OI)
4.72%
3.60%
0.00
1.12%
Gross Profit Margin
7.68%
5.52%
0.00
2.16%
PAT Margin
3.07%
1.59%
0.00
1.48%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 4,462.00 Million
in Mar 2024

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2024 is -1.06% vs -3.79% in Dec 2023

stock-summary

YoY Growth in quarter ended Mar 2024 is 10.63% vs 7.48% in Mar 2023

Quarterly - Consolidate Net Profit
Consolidate Net Profit 136.90 Million
in Mar 2024

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2024 is -16.68% vs 13.78% in Dec 2023

stock-summary

YoY Growth in quarter ended Mar 2024 is 31.38% vs 11.66% in Mar 2023

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 351.70 Million
in Mar 2024

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2024 is -5.81% vs 12.67% in Dec 2023

stock-summary

YoY Growth in quarter ended Mar 2024 is 34.03% vs 7.82% in Mar 2023

Quarterly - Interest
Interest 2.60 Million
in Mar 2024

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2024 is -7.14% vs 86.67% in Dec 2023

stock-summary

YoY Growth in quarter ended Mar 2024 is 188.89% vs 13.92% in Mar 2023

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 4.72%
in Mar 2024

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2024 has fallen from Dec 2023

stock-summary

YoY Growth in quarter ended Mar 2024 has improved from Mar 2023